1. Introduction
Osteoarthritis (OA) of the spine is a common form of arthritis affecting intervertebral discs, vertebral bodies, and zygapophyseal joints in the spinal structure [1,2]. OA can lead to significant morbidity and functional disability over time. Pathologic abnormalities in spine OA include degenerative change of intervertebral discs, deforming spondylosis with vertebral osteophyte formation, and arthritis at the zygapophyseal joints [2]. Lumbar spine OA is considered prevalent, estimated to range from 20% to 85% in the elderly population [3,4,5], due mainly to characteristics of the study population and definition of disease. Low back pain, a typical clinical feature in spine OA, is a common condition motivating visits to healthcare centers and is the second most common cause of disability among the adult US population, with estimates of about 80% affected at sometime during life [6]. A significant proportion of subjects with spine OA is more likely to experience debilitating conditions and poor quality of life.
Recently, the clinical significance of comorbidities in OA has been recognized due to potential effects of comorbid conditions on clinical practices and outcomes, including optimal treatment strategy, expectation of prognosis, health-related quality of life (HRQOL), and health care expenditures [7,8,9,10]. Increases in the prevalence of comorbidities in OA have been observed, with estimates ranging from approximately 50% to 60% of OA patients with at least one comorbidity. Recognition of comorbid conditions in patients with OA might be helpful to reduce pain, physical disability, and disease burden and subsequently improve quality of life [9,10]. Chronic spinal pain is associated with increased probability of comorbidities or decreased HRQOL [11,12]. Lumbar lordosis was found to be a risk factor for reduced physical quality of life in a Japanese study [13]. However, there are insufficient data about comorbid conditions and HRQOL in spine OA. Thus, the objective of this study is to determine the relationships of radiographic spine OA with comorbidities and quality of life in the Korean population.
2. Subjects and Methods
2.1. Study Population
The Korea National Health and Nutrition Examination Survey (KNHANES) is a national cross-sectional survey conducted by the Korea Centers for Disease Control and Prevention to assess population-based health and nutrition in the non-institutionalized Korean population. The KNHANES is conducted by special research teams using individual interviews. Survey participants were selected using a stratified multi-stage cluster probability sampling model to extract representative data about general health and nutritional status in the Korean population after application of the power of sample weight.
For this study, we used data from KNHANES 2012 that are available on the official KNHANES web site (
2.2. Clinical Information
Information for demographic and socioeconomic variables were obtained from interviews with each individual using a well-designed questionnaire for KNHANES 2012. These data included age, sex, body mass index (BMI, kg/m2), marital status (unmarried vs. married), education level (elementary school or less, middle school, high school, and college or higher), income status (low, mid-low, mid-high, and high), alcohol consumption (non-alcoholic vs. alcoholic), and smoking status (never smoker, ex-smoker, and current smoker). BMI is calculated as weight in kilograms divided by height in meters squared. Income level was determined by defining quartiles based on the average monthly income of the study participants.
The questionnaire included questions about comorbid disease, and we confirmed physician diagnoses for all included data. Non-malignant comorbidities included hypertension, myocardial infarction/angina, cerebral infarction, dyslipidemia, pulmonary tuberculosis, bronchial asthma, diabetes mellitus, thyroid disease, depression, atopic dermatitis, chronic renal failure, hepatitis B, hepatitis C, and liver cirrhosis. In addition, malignancies considered comorbidities including gastric cancer, liver cancer, colon cancer, breast cancer, cervical cancer, lung cancer, and thyroid cancer were identified.
2.3. Assessment of Health-Related Quality of Life
Generic health-related quality of life was evaluated using the EuroQOL-5 dimension-3 level (EQ-5D-3L) questionnaire, the EQ-5D index, and the EuroQOL-visual analogue scale (EQ-VAS). The validity and reliability of the EQ-5D were approved as a simple instrument for measuring HRQOL in the Korean population [14]. The EQ-5D is an acceptable and valid measure for assessment of HRQOL in Korean patients with OA [15].
2.4. Radiographic Assessment
Among the total study population, radiographic examinations of the lumbar spine were performed on subjects 50 years of age or older. The radiographic severity of the lumbar spine was evaluated based on Kellgren–Lawrence (K-L) criteria [16]. The K-L grade was classified originally as grade 0 to grade 4 for the knee joint but was modified to grade 0 to grade 2 for the lumbar spine. Radiographic grades for the lumbar spine were determined as follows: K-L grade 0 for normal, K-L grade 1 for suspicious (osteophytes), and K-L grade 2 for abnormal (intervertebral disc space narrowing, bone sclerosis, or large osteophyte) [17]. Radiographic K-L grade 2 was diagnosed as spine OA, and K-L grades 0 and 1 were considered no spine OA.
2.5. Statistical Analysis
Qualitative variables were described as non-weighted number of cases (weighted %), and quantitative variables were described as mean (standard error, SE). Comparisons of qualitative variables were assessed by a composite sample chi-square analysis, whereas a two-sample t-test or Fisher’s exact test was applied to compare quantitative variables.
To analyze the effect of spine OA on the comorbidities and HRQOL, multivariate logistic regression models were performed with malignant or non-malignant comorbidities and HRQOL as dependent variables and spine OA as an independent variable. Associations between variables and spine OA were evaluated by composite sample binary logistic regression analysis after adjustment for confounding variables including age and gender in model 1 and age, gender, marital status, education level, income level, alcohol consumption, and smoking in model 2. The results are presented as 95% confidence intervals (CIs) and odds ratios (ORs). Statistical analyses were performed with IBM SPSS Statistics 19.0 (IBM Corp., Armonk, NY, USA). p values less than 0.05 were considered statistically significant.
3. Results
3.1. Baseline Characteristics of the Study Population
The baseline characteristics of a total of 3256 subjects are described in Table 1. The mean age of the study population was 62.3 (SE 0.2) years, and 1858 subjects (53.8%) were female. The mean BMI was 24.0 kg/m2 (SE 0.1). Data for other characteristics including marital status, education level, income level, alcohol consumption, and smoking are included in Table 1.
We identified frequencies of non-malignant comorbid conditions such as hypertension, myocardial infarction/angina, cerebral infarction, dyslipidemia, bronchial asthma, pulmonary tuberculosis, diabetes mellitus, thyroid disease, depression, atopic dermatitis, chronic renal failure, viral hepatitis, and liver cirrhosis. The frequencies of malignant comorbidities such as gastric cancer, liver cancer, colon cancer, breast cancer, cervical cancer, lung cancer, and thyroid cancer also were identified. Among comorbidities, hypertension (38.2%) was the most common, followed by depression (18.1%) and dyslipidemia (17.3%). The frequencies of malignant comorbidities were estimated to range from 0.1% to 1.1%. In assessment of HRQOL, EQ-VAS score was 85.8 (SE 2.9), and EQ-5D index was 0.90 (SE 0.00).
3.2. Comparison of Characteristics between Spine OA and Controls
Among a total of 3256 subjects enrolled in this study, 1141 had spine OA (32.3%, SE 1.1), and 2115 were control subjects (without spine OA) (67.7%, SE 1.1) (Table 1). Subjects with spine OA were older (p < 0.001) and more likely to be female (p = 0.001). There was no difference in BMI between groups. Other variables including marital status, education level, income level, alcohol consumption, and smoking status were significantly different between the two groups.
Comparing the frequencies of comorbidities, subjects with spine OA had higher frequencies of hypertension, myocardial infarction/angina, cerebral infarction, and diabetes mellitus than controls (p < 0.001, p = 0.022, p = 0.016, and p = 0.029, respectively), whereas dyslipidemia was more common in controls (p = 0.005). In contrast, there were no differences of malignancies between controls and spine OA. The mean number of comorbid conditions in spine OA was 1.40 (SE 0.05), and that in controls was 1.20 (SE 0.03), a significant difference (p = 0.001). In addition, the control group had a significantly higher proportion of participants without comorbidities than the spine OA group (35.0% vs. 28.0%) (Figure 1). As the number of comorbidities increased, the proportion of spine OA subjects tended to increase compared to controls.
In comparison of HRQOL, spine OA was associated with significantly lower EQ-5D index than were controls (p < 0.001) (Table 1). However, there was no difference in EQ-VAS score between groups (p = 0.414). As the number of comorbidities increased in spine OA, the EQ-5D index gradually and significantly decreased (p for trend < 0.001) (Figure 2A). However, the relationship between number of comorbidities and EQ-VAS was not significant (Figure 2B).
Data were described as mean and standard error.
3.3. Relationships between Spine OA and Comorbid Conditions
In the multivariate binary logistic regression analysis in the comparison of spine OA and controls, there was a decreased risk of pulmonary tuberculosis in spine OA in model 1 (OR 0.685, 95% CI 0.495–0.947, p = 0.022) (Table 2). In contrast, spine OA was not associated with the risk of other non-malignant comorbid conditions. In model 2, spine OA was significantly associated with an increased risk of hypertension (OR 1.219, 95% CI 1.020–1.456, p = 0.030), but it was not linked with those of other comorbidities.
In the logistic regression analysis with malignant comorbidities as the dependent variables in the comparison of spine OA and controls, model 1 revealed that spine OA showed lower risk of colon cancer (OR 0.185, 95% CI 0.077–0.443, p < 0.001) compared to controls (Table 3). Similarly, spine OA had a negative association with the risk of colon cancer (OR 0.200, 95% CI 0.079–0.505, p = 0.001) in model 2.
In the comparison of spine OA and controls, there was an increased risk of lower EQ-5D index score in spine OA in model 1 (OR 0.272, 95% CI 0.121–0.615, p = 0.002), but it was not related to EQ-VAS score (p = 0.478) (Table 4). Consistently, model 2 confirmed that spine OA was related with lower EQ-5D index (OR 0.256, 95% CI 0.110–0.595, p = 0.002), but it was not related to EQ-VAS score (p = 0.470).
4. Discussion
Although many studies have been conducted on the relationships between OA and comorbidities, there remain debates about the nature of the relationship. Moreover, previous studies have focused on patients with knee or hip OA, and there are insufficient studies on the roles of comorbidities and HRQOL in spine OA. In this study, we investigated comorbidities and quality of life in subjects over 50 years of age with radiographic spine OA using data from a national population-based health and nutrition survey. The main finding of this study was that comorbid diseases such as hypertension and colon cancer were associated with radiographic spine OA as defined using the K-L grade scale. In addition, we found that subjects with spine OA are vulnerable to poor quality of life, as shown by lower EQ-5D index.
Growing evidence suggests a close relationship between hypertension and OA. A meta-analysis of eight cohort or cross-sectional studies with 9765 subjects found significant association between hypertension and radiographic or symptomatic knee OA [18]. In an analysis of data from a 3-year follow-up of the ROAD study, hypertension was significantly responsible for development and progression of knee OA (OR 2.74, p = 0.008 and OR 1.54, p = 0.012, respectively) [19]. A nationwide study of registered subjects who underwent primary total hip or knee replacements found that hypertension was significantly associated with early revision after total knee joint replacement surgery, suggesting that hypertension might contribute to poor clinical outcomes after knee surgery [20]. Consistent with these findings, we also found a close association between spine OA and hypertension, although studies of this relationship have not been conducted in individuals with lumbar spine OA. However, the relationship between hypertension and risk of OA remains controversial. Low systolic blood pressure was significantly associated with OA at the knee, hand, and hip joint in an analysis of data from 384,838 unrelated participants in the UK Biobank study [21]. The precise mechanism underlying the relationship between hypertension and OA has not been determined. Clinically, metabolic syndrome and its components have been regarded as independent risk factors for knee or hip OA [22]. Considering that hypertension is a metabolic syndrome component, it might be clinically linked to spine OA. In terms of vascular pathogenic mechanisms, OA is a joint disease characterized by impaired perfusion to subchondral bone and ischemia in local joint tissues, which results in development of hypoxia and lack of nutritional supply within articular structures [23]. In addition to disruption of the local vascular environment, systemic vascular abnormalities such as hypertension could play an important role in the pathogenesis of OA. In an animal study, hypertension was found to be potentially responsible for disturbances of balance in both arterial and venous blood flow [24]. Furthermore, increased interosseous pressure and disturbance of perfusion by hypertension led to dysregulation of bone remodeling in response to mechanical stress [25]. Based on this evidence, hypertension might contribute to the development of OA through derangement of local vascular homeostasis in joint structure components of the spine.
It has been well established that systemic inflammation plays a crucial role in the pathogenesis of atherosclerosis and development of cardiovascular diseases [26]. Recently, evidence has been presented that OA is a low-grade inflammatory disease [27]. Evidence supporting the association of OA with cardiovascular disease has accumulated. A meta-analysis of the potential association between OA and cardiovascular disease using 15 observational studies demonstrated that the risk of cardiovascular disease increased by 24% in patients with OA compared to the general population (relative risk 1.24, p < 0.001) [28]. In a prospective study from the Progetto Veneto Anziano Study Cohort, subjects with OA were more likely to develop new onset cardiovascular diseases than were those without OA, and the presence of OA contributed to increased risk of cardiovascular disease [29]. Based on these findings, OA is a significant risk factor or predictor of cardiovascular disease. In contrast, OA was not associated with coronary heart disease risk factors or with its 8-year incidence in a sample of elderly Japanese American males who participated in the Honolulu Heart Program’s fourth examination from 1991 to 1993 [30]. Consistent with the result of that observational study in Japanese American subjects, our study did not detect relationships between cardiovascular diseases such as ischemic heart disease or cerebral infarction and OA.
There is lack of epidemiologic data about malignancy and OA. In the nationwide Danish Hospital Discharge Registry, the risk of cancer did not increase among subjects who received knee or hip joint replacements [31]. Radiographic knee OA with pain was not associated with malignancies including lung cancer, cervical cancer, breast cancer, colon cancer, and stomach cancer compared to non-knee OA in KNHANES data [32]. In contrast, increased cancer risk was evident in the liver, pancreas, breast, and bladder among subjects with knee OA aged 40 years or older in the Information System for Research in Primary Care (SIDIAP) database [33]. Ward et al. found that patients with knee or hip OA were at lower risk of colorectal and lung cancer compared to the general population in a retrospective cohort study [34]. Similar to prior results, we also observed lower risk of colon cancer in spine OA patients compared to controls. To explain the low risk of colon cancer in subjects with spine OA, consideration should be given to the use of medications such as nonsteroidal anti-inflammatory drugs (NSAIDs). Long-term use of non-selective NSAIDs has been linked to lower risk of gastrointestinal cancers [35]. Although the KNHANES data did not provide clinical information regarding the use of NSAIDs, we assumed that medications used to treat spine OA such as NSAIDs were related to lower risk of colon cancer.
OA is a disease that has a profound impact on quality of life because the disease is chronic and sometimes incurable and can lead to disability [36]. HRQOL assesses each subject’s functional status in daily life and subjective perceptions of well-being. To measure HRQOL in this study, we used EQ-5D. We found that subjects with spine OA had lower EQ-5D index compared to those without spine OA. Consistently, doctor-diagnosed knee OA was negatively associated with HRQOL assessed using the Knee Injury and Osteoarthritis Outcome Score-Quality of Life [37]. Jeong et al. also observed lower EQ-5D index in knee OA than in patients without knee OA and negative associations between HRQOL indexes and knee OA [32]. In a comparison between older adults with hip and/or knee OA and those without OA, subjects with OA of the lower extremities showed significant effects on multiple dimensions of the Study Short Form-36 item health status questionnaire (SF-36) [38]. Consistent with the findings of our study, Imagama et al. observed negative impact of increased comorbidities on physical QOL in patients with lumbar lordosis [13]. We also found no difference in EQ-VAS score between subjects with and without spine OA. In another study using KNHANES data, EQ-VAS was significantly lower in subjects with knee OA with pain than in subjects without knee OA [32]. However, subjects with knee OA but without knee pain had similar EQ-VQS as those without knee OA. As in our study, the reason underlying the similarity of EQ-VAS in spine OA and control group is hypothesized as follows. Osteophytes, one of the criteria used for classification of spine OA, is weakly related to low back pain, while disc space narrowing is moderately associated with back pain [39]. In addition to the vertebral body, the facet joints of the vertebrae can be associated with low back pain; in a recent study, facet joint OA confirmed by computed tomography was not associated with low back pain [40]. Additional research on the relationship between spine OA and low back pain is needed.
There are some limitations impairing the explanation of the relationship between comorbidity and spine OA. First, detailed information about OA-related medications was lacking from KNHANES 2012. Our main finding, that hypertension and colon cancer were associated with spine OA, might be attributable to the use of therapeutic drugs such as aspirin or NSAIDs. Second, our ability to identify other comorbidities present in other body organs and tissues in subjects with spine OA was limited because the types of comorbidities in this study were not well-defined. Third, we lacked a well-designed questionnaire about back pain, which would be necessary to explain why we observed no difference in EQ-VAS between spine OA patients and controls. It is difficult to confirm the relationship between back pain and EQ-VAS because the questionnaire did not include a clear definition of low back pain. Fourth, another limitation is the lack of information about patterns of physical activity and sedentary behavior that can affect spine OA.
In conclusion, we found that subjects with spine OA were more likely to have comorbid conditions than subjects without spine OA. Hypertension was positively associated with spine OA among non-malignant comorbidities, whereas spine OA was associated with lower colon cancer risk than were the controls. In addition, subjects with spine OA showed lower EQ-5D index than controls, suggesting that spine OA had a potent negative impact on HRQOL. By identifying comorbidities and lower HRQOL in subjects with spine OA, physicians should be concerned about and address comorbidities and quality of life when managing patients with spine OA.
Study concept and design, S.-K.K.; data analysis and interpretation, S.-K.K., J.-Y.C.; drafting of the article, S.-K.K.; critical revision of the article, S.-K.K. All authors have read and agreed to the published version of the manuscript.
This research received no external funding.
This study was performed according to the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the Institutional Review Board at Daegu Catholic University Medical Center (CR-21-133; approval date 25 August 2021).
Informed consent was obtained from all subjects involved in the study.
The raw, anonymized data are publicly available from KNHANES 2012 on the official KNHANES web site (
There are no financial and non-financial conflicts of interest for any of the authors regarding specific financial interests that are relevant to the work conducted or reported in this manuscript.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Enlarge this image.Figure 1. Distribution of proportion of controls and subjects with spine OA according to the number of comorbidities. Abbreviation: OA, osteoarthritis.
Enlarge this image.Figure 2. Distribution of health-related quality of life according to the number of comorbidities in subjects with spine OA (A) EQ-5D index according to comorbidities. (B) EQ-VAS according to comorbidities. Abbreviation: EQ-VAS score, EuroQOL visual analogue scale scores; EQ-5D index, EuroQOL-5dimension index.
Comparison of variables between controls and subjects with spine OA (n = 3.256).
| Variables | Total |
Controls |
Spine OA |
p-Value * |
|---|---|---|---|---|
| Age (years) | 62.3 (0.2) | 59.8 (0.3) | 67.5 (0.4) | <0.001 |
| Gender (female, n, %) | 1858 (53.8) | 1161 (50.7) | 697 (60.1) | 0.001 |
| Body mass index (kg/m2) | 24.0 (0.1) | 24.0 (0.1) | 23.9 (0.1) | 0.988 |
| Marital status (n, %) † | 0.001 | |||
| Unmarried | 695 (19.4) | 33 (2.0) | 3 (0.3) | |
| Married | 2475 (80.6) | 2078 (98.0) | 1137 (99.7) | |
| Education (n, %) † | <0.001 | |||
| Elementary school or less | 1501 (45.2) | 808 (37.7) | 693 (61.1) | |
| Middle school | 539 (19.4) | 379 (20.8) | 160 (16.4) | |
| High school | 753 (24.0) | 579 (27.9) | 174 (15.7) | |
| College or higher | 380 (11.4) | 302 (13.6) | 78 (6.7) | |
| Income (n, %) † | 0.016 | |||
| Low | 806 (26.9) | 513 (27.1) | 293 (26.6) | |
| Mid-low | 817 (26.5) | 506 (25.5) | 311 (28.6) | |
| Mid-high | 808 (24.7) | 526 (24.2) | 282 (25.7) | |
| High | 790 (21.9) | 547 (23.2) | 243 (19.1) | |
| Alcohol consumption (n, %) † | <0.001 | |||
| Non-alcoholic | 695 (19.4) | 401 (16.8) | 294 (25.0) | |
| Alcoholic | 2475 (80.6) | 1668 (83.2) | 807 (75.0) | |
| Smoking (n, %) † | 0.043 | |||
| Never smoker | 1842 (55.7) | 1178 (53.5) | 664 (60.3) | |
| Ex-smoker | 788 (25.1) | 519 (25.4) | 268 (24.7) | |
| Current smoker | 502 (19.2) | 351 (21.1) | 151 (15.0) | |
| Comorbidities † | ||||
| Hypertension | 1298 (38.2) | 751 (33.2) | 547 (48.8) | <0.001 |
| Myocardial infarction/angina | 170 (4.8) | 97 (4.0) | 73 (6.4) | 0.022 |
| Cerebral infarction | 135 (3.9) | 75 (3.2) | 60 (5.5) | 0.016 |
| Dyslipidemia | 623 (17.3) | 436 (18.1) | 187 (15.5) | 0.005 |
| Bronchial asthma | 215 (6.7) | 129 (6.2) | 86 (7.7) | 1.000 |
| Pulmonary tuberculosis | 281 (8.8) | 196 (9.4) | 85 (7.6) | 0.091 |
| Diabetes mellitus | 485 (14.8) | 295 (13.9) | 190 (16.6) | 0.029 |
| Thyroid disease | 167 (4.4) | 107 (4.3) | 60 (4.8) | 0.756 |
| Depression | 584 (18.1) | 377 (17.7) | 207 (19.1) | 0.722 |
| Atopic dermatitis | 82 (2.5) | 56 (2.3) | 26 (2.9) | 0.550 |
| Chronic renal failure | 22 (0.6) | 15 (0.6) | 7 (0.5) | 0.767 |
| Hepatitis B | 55 (1.7) | 39 (2.0) | 16 (1.2) | 0.369 |
| Hepatitis C | 9 (0.2) | 8 (0.2) | 1 (0.2) | 0.135 |
| Liver cirrhosis | 16 (0.4) | 11 (0.5) | 5 (0.2) | 0.764 |
| Gastric cancer | 38 (1.1) | 25 (1.0) | 13 (1.2) | 0.938 |
| Liver cancer | 4 (0.1) | 3 (0.1) | 1 (0.1) | 0.566 |
| Colon cancer | 4 (0.1) | 27 (1.3) | 7 (0.5) | 0.080 |
| Breast cancer | 34 (1.1) | 16 (0.6) | 5 (0.3) | 0.288 |
| Cervical cancer | 21 (0.5) | 13 (0.5) | 6 (0.5) | 0.767 |
| Lung cancer | 19 (0.5) | 2 (0.1) | 2 (0.1) | 0.434 |
| Thyroid cancer | 4 (0.1) | 18 (0.8) | 4 (0.4) | 0.100 |
| EQ-VAS score | 85.8 (2.9) | 82.6 (3.2) | 92.3 (6.3) | 0.414 |
| EQ-5D index | 0.90 (0.00) | 0.92 (0.00) | 0.85 (0.01) | <0.001 |
Data were described as non-weighted number of cases (weighted %) for qualitative variables or mean (standard error, SE) for quantitative variables. Abbreviation: OA, osteoarthritis; EQ-VAS score, EuroQOL visual analogue scale scores; EQ-5D index, EuroQOL-5dimension index. * p values were obtained by two sample t-test or chi-square test or Fisher’s exact test. † Missing data were excluded from the analyses: for marriage, n = 5; for education, n = 83; for income, n = 35; for alcohol consumption, n = 86; for smoking, n = 124; comorbidities, n = 79.
Multivariate-adjusted ORs (95% CIs) for non-malignant comorbidities in spine OA compared to controls.
| Model 1 | Model 2 | |||||
|---|---|---|---|---|---|---|
| Variables | OR | 95% CI | p Value | OR | 95% CI | p-Value |
| Hypertension | 1.188 | 0.990–1.426 | 0.064 | 1.219 | 1.020–1.456 | 0.030 |
| Myocardial infarction/angina | 1.116 | 0.760–1.640 | 0.574 | 1.088 | 0.725–1.635 | 0.681 |
| Cerebral infarction | 1.083 | 0.657–1.787 | 0.753 | 0.068 | 0.635–1.798 | 0.802 |
| Dyslipidemia | 0.795 | 0.614–1.029 | 0.081 | 0.826 | 0.632–1.079 | 0.160 |
| Bronchial asthma | 0.940 | 0.646–1.367 | 0.744 | 0.937 | 0.640–1.373 | 0.738 |
| Pulmonary tuberculosis | 0.685 | 0.495–0.947 | 0.022 | 0.743 | 0.531–1.039 | 0.082 |
| Diabetes mellitus | 0.961 | 0.728–1.268 | 0.775 | 0.978 | 0.735–1.303 | 0.880 |
| Thyroid disease | 1.090 | 0.733–1.620 | 0.669 | 1.066 | 0.717–1.585 | 0.752 |
| Depression | 1.147 | 0.882–1.492 | 0.303 | 1.119 | 0.850–1.474 | 0.420 |
| Atopic dermatitis | 1.532 | 0.775–3.031 | 0.218 | 1.752 | 0.866–3.544 | 0.118 |
| Chronic renal failure | 0.700 | 0.238–2.060 | 0.515 | 0.659 | 0.234–1.859 | 0.429 |
| Hepatitis B | 0.865 | 0.478–1.565 | 0.630 | 0.874 | 0.483–1.581 | 0.654 |
| Hepatitis C | 0.571 | 0.043–7.594 | 0.669 | 0.664 | 0.054–8.148 | 0.748 |
| Liver cirrhosis | 0.564 | 0.203–1.571 | 0.272 | 0.531 | 0.183–1.547 | 0.244 |
Data were described as odds ratio (OR) and 95% confidence intervals (CIs). Abbreviation: OA, osteoarthritis. p values were obtained by the composite sample multivariate logistic regression analysis: Model 1, adjusted with age and gender; Model 2, adjusted with age, gender, marital status, education level, income level, alcohol consumption, and smoking.
Multivariate-adjusted ORs (95% CIs) for malignant comorbidities in spine OA compared to controls.
| Model 1 | Model 2 | |||||
|---|---|---|---|---|---|---|
| Variables | OR | 95% CI | p Value | OR | 95% CI | p Value |
| Gastric cancer | 0.829 | 0.421–1.632 | 0.586 | 0.763 | 0.373–1.562 | 0.457 |
| Liver cancer | 1.337 | 0.114–15.641 | 0.816 | 1.517 | 0.139–16.608 | 0.732 |
| Colon cancer | 0.185 | 0.077–0.443 | <0.001 | 0.200 | 0.079–0.505 | 0.001 |
| Breast cancer | 0.314 | 0.093–1.067 | 0.063 | 0.333 | 0.101–1.094 | 0.070 |
| Cervical cancer | 0.674 | 0.138–3.281 | 0.623 | 0.463 | 0.065–3.307 | 0.441 |
| Lung cancer | 2.756 | 0.663–11.446 | 0.162 | 2.899 | 0.685–12.271 | 0.147 |
| Thyroid cancer | 0.641 | 0.232–1.774 | 0.390 | 0.639 | 0.227–1.799 | 0.394 |
Data were described as odds ratio (OR) and 95% confidence intervals (CIs). Abbreviation: OA, osteoarthritis. p values were obtained by the composite sample multivariate logistic regression analysis: Model 1, adjusted with age and gender; Model 2, adjusted with age, gender, marital status, education level, income level, alcohol consumption, and smoking.
Multivariate-adjusted ORs (95% CIs) for health-related quality of life in spine OA compared to controls.
| Model 1 | Model 2 | |||||
|---|---|---|---|---|---|---|
| Variables | OR | 95% CI | p Value | OR | 95% CI | p Value |
| EQ-VAS score | 1.000 | 0.999–1.001 | 0.478 | 1.000 | 0.999–1.001 | 0.470 |
| EQ-5D index | 0.272 | 0.121–0.615 | 0.002 | 0.256 | 0.110–0.595 | 0.002 |
Data were described as odds ratio (OR) and 95% confidence intervals (CIs). Abbreviation: OA, osteoarthritis; EQ-VAS score, EuroQOL visual analogue scale scores; EQ-5D index, EuroQOL-5dimension index. p values were obtained by the composite sample multivariate logistic regression analysis: Model 1, adjusted with age and gender; Model 2, adjusted with age, gender, marriage, education, income, alcohol consumption, and smoking.
References
1. Laplante, B.L.; DePalma, M.J. Spine osteoarthritis. PM R; 2012; 4, pp. S28-S36. [DOI: https://dx.doi.org/10.1016/j.pmrj.2012.03.005] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22632699]
2. Sarzi-Puttini, P.; Atzeni, F.; Fumagalli, M.; Capsoni, F.; Carrabba, M. Osteoarthritis of the spine. Semin. Arthritis. Rheum.; 2005; 34, pp. 38-43. [DOI: https://dx.doi.org/10.1016/j.semarthrit.2004.03.011]
3. Kellgren, J.H.; Lawrence, J.S. Osteoarthritis and disc degeneration in an urban population. Ann. Rheum. Dis.; 1958; 17, pp. 388-397. [DOI: https://dx.doi.org/10.1136/ard.17.4.388] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/13606727]
4. Van Saase, J.L.; Van Romunde, L.K.; Cats, A.; Vandenbroucke, J.P.; Valkenburg, H.A. Epidemiology of osteoarthritis: Zoetemer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations. Ann. Rheum. Dis.; 1989; 48, pp. 271-280. [DOI: https://dx.doi.org/10.1136/ard.48.4.271] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/2712610]
5. Battié, M.C.; Videman, T.; Parent, E. Lumbar disc degeneration: Epidemiology and genetic influences. Spine; 2004; 29, pp. 2679-2690. [DOI: https://dx.doi.org/10.1097/01.brs.0000146457.83240.eb]
6. Centers for Disease Control and Prevention (CDC). Prevalence of disabilities and associated health conditions among adults—United States, 1999. JAMA; 2001; 285, pp. 1571-1572.
7. Marshall, D.A.; Liu, X.; Barnabe, C.; Yee, K.; Faris, P.D.; Barber, C.; Mosher, D.; Noseworthy, T.; Werle, J.; Lix, L. Existing comorbidities in people with osteoarthritis: A retrospective analysis of a population-based cohort in Alberta, Canada. BMJ Open; 2019; 9, e033334. [DOI: https://dx.doi.org/10.1136/bmjopen-2019-033334] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31753902]
8. Swain, S.; Sarmanova, A.; Coupland, C.; Doherty, M.; Zhang, W. Comorbidities in Osteoarthritis: A Systematic Review and Meta-Analysis of Observational Studies. Arthritis Care. Res.; 2020; 72, pp. 991-1000. [DOI: https://dx.doi.org/10.1002/acr.24008]
9. Muckelt, P.E.; Roos, E.M.; Stokes, M.; McDonough, S.; Grønne, D.T.; Ewings, S.; Skou, S.T. Comorbidities and their link with individual health status: A cross-sectional analysis of 23,892 people with knee and hip osteoarthritis from primary care. J. Comorb.; 2020; 10, 2235042X20920456. [DOI: https://dx.doi.org/10.1177/2235042X20920456]
10. Calders, P.; Van Ginckel, A. Presence of comorbidities and prognosis of clinical symptoms in knee and/or hip osteoarthritis: A systematic review and meta-analysis. Semin. Arthritis Rheum.; 2018; 47, pp. 805-813. [DOI: https://dx.doi.org/10.1016/j.semarthrit.2017.10.016]
11. Gureje, O.; Akinpelu, A.O.; Uwakwe, R.; Udofia, O.; Wakil, A. Comorbidity and impact of chronic spinal pain in Nigeria. Spine; 2007; 32, pp. E495-E500. [DOI: https://dx.doi.org/10.1097/BRS.0b013e31810768fc]
12. de Luca, K.E.; Parkinson, L.; Haldeman, S.; Byles, J.E.; Blyth, F. The Relationship Between Spinal Pain and Comorbidity: A Cross-sectional Analysis of 579 Community-Dwelling, Older Australian Women. J. Manip. Physiol. Ther.; 2017; 40, pp. 459-466. [DOI: https://dx.doi.org/10.1016/j.jmpt.2017.06.004]
13. Imagama, S.; Ando, K.; Kobayashi, K.; Seki, T.; Hamada, T.; Machino, M.; Ota, K.; Tanaka, S.; Morozumi, M.; Kanbara, S. et al. Impact of comorbidity rates of lumbar spondylosis, knee osteoarthritis, and osteoporosis on physical QOL and risk factors for poor physical QOL in middle-aged and elderly people. Mod. Rheumatol.; 2020; 30, pp. 402-409. [DOI: https://dx.doi.org/10.1080/14397595.2019.1601839] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30924379]
14. Jo, M.W.; Lee, S.I. Validity and Reliability of Korean EQ-5D Valuation Study Using the Time-trade off Method. Korean J. Health Promot. Dis. Prev.; 2007; 7, pp. 96-103.
15. Lim, N.Y.; Lee, I.; Lee, E.N.; Lee, K.S.; Cho, K.S.; Rhee, S.; Kang, H.S.; Kim, K.S.; Kim, J.I.; Bak, W.S. et al. Validation Study of EQ-5D in the Patients with Osteoarthritis. J. Muscle Jt. Health; 2010; 17, pp. 203-211. [DOI: https://dx.doi.org/10.5953/JMJH.2010.17.2.203]
16. Kellgren, J.H.; Lawrence, J.S. Radiological assessment of osteoarthrosis. Ann. Rheum. Dis.; 1957; 16, pp. 494-502. [DOI: https://dx.doi.org/10.1136/ard.16.4.494] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/13498604]
17. Yoshimura, N.; Muraki, S.; Oka, H.; Mabuchi, A.; En-Yo, Y.; Yoshida, M.; Saika, A.; Yoshida, H.; Suzuki, T.; Yamamoto, S. et al. Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: The research on osteoarthritis/osteoporosis against disability study. J. Bone Miner. Metab.; 2009; 27, pp. 620-628. [DOI: https://dx.doi.org/10.1007/s00774-009-0080-8]
18. Zhang, Y.M.; Wang, J.; Liu, X.G. Association between hypertension and risk of knee osteoarthritis: A meta-analysis of observational studies. Medicine; 2017; 96, e7584. [DOI: https://dx.doi.org/10.1097/MD.0000000000007584]
19. Yoshimura, N.; Muraki, S.; Oka, H.; Tanaka, S.; Kawaguchi, H.; Nakamura, K.; Akune, T. Accumulation of metabolic risk factors such as overweight, hypertension, dyslipidaemia, and impaired glucose tolerance raises the risk of occurrence and progression of knee osteoarthritis: A 3-year follow-up of the ROAD study. Osteoarthr. Cartil.; 2012; 20, pp. 1217-1226. [DOI: https://dx.doi.org/10.1016/j.joca.2012.06.006] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22796312]
20. Jämsen, E.; Peltola, M.; Eskelinen, A.; Lehto, M.U. Comorbid diseases as predictors of survival of primary total hip and knee replacements: A nationwide register-based study of 96,754 operations on patients with primary osteoarthritis. Ann. Rheum. Dis.; 2013; 72, pp. 1975-1982. [DOI: https://dx.doi.org/10.1136/annrheumdis-2012-202064]
21. Funck-Brentano, T.; Nethander, M.; Movérare-Skrtic, S.; Richette, P.; Ohlsson, C. Causal Factors for Knee, Hip, and Hand Osteoarthritis: A Mendelian Randomization Study in the UK Biobank. Arthritis Rheumatol.; 2019; 71, pp. 1634-1641. [DOI: https://dx.doi.org/10.1002/art.40928]
22. Engström, G.; de Verdier, M.G.; Rollof, J.; Nilsson, P.M.; Lohmander, L.S. C-reactive protein, metabolic syndrome and incidence of severe hip and knee osteoarthritis. A population-based cohort study. Osteoarthr. Cartil.; 2009; 17, pp. 168-173. [DOI: https://dx.doi.org/10.1016/j.joca.2008.07.003]
23. Ching, K.; Houard, X.; Berenbaum, F.; Wen, C. Hypertension meets osteoarthritis—Revisiting the vascular aetiology hypothesis. Nat. Rev. Rheumatol.; 2021; 17, pp. 533-549. [DOI: https://dx.doi.org/10.1038/s41584-021-00650-x]
24. De Lorenzo, R.A.; Ward, J.A.; Jordan, B.S.; Hanson, C.E. Relationships of intraosseous and systemic pressure waveforms in a Swine model. Acad. Emerg. Med.; 2014; 21, pp. 899-904. [DOI: https://dx.doi.org/10.1111/acem.12432] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25154326]
25. Aaron, R.K.; Dyke, J.P.; Ciombor, D.M.; Ballon, D.; Lee, J.; Jung, E.; Tung, G.A. Perfusion abnormalities in subchondral bone associated with marrow edema, osteoarthritis, and avascular necrosis. Ann. N. Y. Acad. Sci.; 2007; 1117, pp. 124-137. [DOI: https://dx.doi.org/10.1196/annals.1402.069] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18056039]
26. van Leuven, S.I.; Franssen, R.; Kastelein, J.J.; Levi, M.; Stroes, E.S.; Tak, P.P. Systemic inflammation as a risk factor for atherothrombosis. Rheumatology; 2008; 47, pp. 3-7. [DOI: https://dx.doi.org/10.1093/rheumatology/kem202]
27. Chow, Y.Y.; Chin, K.Y. The Role of Inflammation in the Pathogenesis of Osteoarthritis. Mediat. Inflamm.; 2020; 2020, 8293921. [DOI: https://dx.doi.org/10.1155/2020/8293921]
28. Wang, H.; Bai, J.; He, B.; Hu, X.; Liu, D. Osteoarthritis and the risk of cardiovascular disease: A meta-analysis of observational studies. Sci. Rep.; 2016; 6, 39672. [DOI: https://dx.doi.org/10.1038/srep39672]
29. Veronese, N.; Trevisan, C.; De Rui, M.; Bolzetta, F.; Maggi, S.; Zambon, S.; Musacchio, E.; Sartori, L.; Perissinotto, E.; Crepaldi, G. et al. Association of Osteoarthritis with Increased Risk of Cardiovascular Diseases in the Elderly: Findings From the Progetto Veneto Anziano Study Cohort. Arthritis. Rheumatol.; 2016; 68, pp. 1136-1144. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26714002]
30. Kishimoto, M.; Greenberg, J.; Lee, R.; Masaki, K.H.; Chen, R.; Rodriguez, B.L.; Blanchette, P.; Pillinger, M.; David Curb, J. Arthritis as a risk factor for incident coronary heart disease in elderly Japanese-American males—The Honolulu Heart Program. Bull. NYU Hosp. Jt. Dis.; 2009; 67, pp. 230-235.
31. Olsen, J.H.; McLaughlin, J.K.; Nyrén, O.; Mellemkjaer, L.; Lipworth, L.; Blot, W.J.; Fraumeni, J.F., Jr. Hip and knee implantations among patients with osteoarthritis and risk of cancer: A record-linkage study from Denmark. Int. J. Cancer; 1999; 81, pp. 719-722. [DOI: https://dx.doi.org/10.1002/(SICI)1097-0215(19990531)81:5<719::AID-IJC8>3.0.CO;2-D]
32. Jeong, H.; Baek, S.Y.; Kim, S.W.; Eun, Y.H.; Kim, I.Y.; Lee, J.; Jeon, C.H.; Koh, E.M.; Cha, H.S. Comorbidities and health-related quality of life in Koreans with knee osteoarthritis: Data from the Korean National Health and Nutrition Examination Survey (KNHANES). PLoS ONE; 2017; 12, e0186141. [DOI: https://dx.doi.org/10.1371/journal.pone.0186141]
33. Turkiewicz, A.; Díaz, Y.; Poveda-Marina, J.L.; Duarte-Salles, T. Knee osteoarthritis and risk of ten cancers in a large real-world matched cohort study. Osteoarthr. Cartil.; 2020; 28, pp. S421-S422. [DOI: https://dx.doi.org/10.1016/j.joca.2020.02.654]
34. Ward, M.M.; Alehashemi, S. Risks of solid cancers in elderly persons with osteoarthritis or ankylosing spondylitis. Rheumatology; 2020; 59, pp. 3817-3825. [DOI: https://dx.doi.org/10.1093/rheumatology/keaa166]
35. Brusselaers, N.; Lagergren, J. Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden. BMJ Open; 2018; 8, e021869. [DOI: https://dx.doi.org/10.1136/bmjopen-2018-021869]
36. Hill, C.L.; Parsons, J.; Taylor, A.; Leach, G. Health related quality of life in a population sample with arthritis. J. Rheumatol.; 1999; 26, pp. 2029-2035. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/10493687]
37. Vennu, V.; Bindawas, S.M. Relationship between falls, knee osteoarthritis, and health-related quality of life: Data from the Osteoarthritis Initiative study. Clin. Interv. Aging; 2014; 9, pp. 793-800. [DOI: https://dx.doi.org/10.2147/CIA.S62207] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24855348]
38. Salaffi, F.; Carotti, M.; Stancati, A.; Grassi, W. Health-related quality of life in older adults with symptomatic hip and knee osteoarthritis: A comparison with matched healthy controls. Aging Clin. Exp. Res.; 2005; 17, pp. 255-263. [DOI: https://dx.doi.org/10.1007/BF03324607] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16285189]
39. Goode, A.P.; Carey, T.S.; Jordan, J.M. Low back pain and lumbar spine osteoarthritis: How are they related?. Curr. Rheumatol. Rep.; 2013; 15, 305. [DOI: https://dx.doi.org/10.1007/s11926-012-0305-z] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23307577]
40. Kalichman, L.; Li, L.; Kim, D.H.; Guermazi, A.; Berkin, V.; O’Donnell, C.J.; Hoffmann, U.; Cole, R.; Hunter, D.J. Facet joint osteoarthritis and low back pain in the community-based population. Spine; 2008; 33, pp. 2560-2565. [DOI: https://dx.doi.org/10.1097/BRS.0b013e318184ef95]
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Details
; Jung-Yoon, Choe